STI
7
2
TGNA
56
-2
DTE
40
4
NWL
58
-3
STZ
44
-3
ES
50
3
PHM
43
-3
CAT
66
2
MET
63
-4
AIV
39
-2
PAYX
32
-4
AEP
64
5
LRCX
71
22
PCG
72
2
MRK
60
2
NI
67
4
LMT
55
-4
CME
42
-8
KMX
47
3
IR
55
-11
STI
7
2
TGNA
56
-2
DTE
40
4
NWL
58
-3
STZ
44
-3
ES
50
3
PHM
43
-3
CAT
66
2
MET
63
-4
AIV
39
-2
PAYX
32
-4
AEP
64
5
LRCX
71
22
PCG
72
2
MRK
60
2
NI
67
4
LMT
55
-4
CME
42
-8
KMX
47
3
IR
55
-11
Financhill
Back

INNOVATE Corp. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
47

VATE
INNOVATE Corp.

Last Price:
$5.25
Seasonality Move:
11.43%
Sell
31

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
47
INNOVATE Corp. (VATE) is a Sell

Is INNOVATE Corp. a Buy, Sell or Hold?

  • The current INNOVATE Corp. [VATE] share price is $5.38. The Score for VATE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VATE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $65.99. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VATE Stock Price Chart

What is INNOVATE Corp.'s stock price today?

  • The INNOVATE Corp. share price today is $5.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VATE is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $65.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

VATE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.71 Buy
Relative Strength Index (14 RSI): 60.72 Buy
Chaikin Money Flow: 60586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.63 - 5.23) Buy
Bollinger Bands (100): (4.59 - 5.41) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.42 Sell
Relative Strength Index (14 RSI): 32.25 Sell
Chaikin Money Flow: -36886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.08 - 86.32) Sell
Bollinger Bands (100): (45.17 - 89.09) Sell

VATE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.64 Buy
20-day SMA: 4.88 Buy
50-day SMA: 5.04 Buy
200-day SMA: 5.65 Sell
8-day EMA: 1.98 Buy
20-day EMA: 0.9 Buy
50-day EMA: 0.38 Buy
200-day EMA: 0.1 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.2 Sell
20-day SMA: 79.37 Sell
50-day SMA: 82.12 Sell
200-day SMA: 52.13 Buy
8-day EMA: 72.25 Sell
20-day EMA: 76.67 Sell
50-day EMA: 77.13 Sell
200-day EMA: 56.56 Buy

INNOVATE Corp. Earnings Growth & VATE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

INNOVATE Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):